🔎 Trials Near Me

Home › Liver Cancer (Hepatocellular Carcinoma) › Ohio › Cleveland

Liver Cancer (Hepatocellular Carcinoma) clinical trials in Cleveland, OH

18 studies for Liver Cancer (Hepatocellular Carcinoma) are looking for participants at sites in and around Cleveland (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

The Vanguard Study: Testing a New Way to Screen for Cancer

RecruitingHealthy volunteers welcome
  • Louis Stokes Cleveland VA Medical Center, Cleveland
Ages 45 to 75 · All sexes · Updated Oct 5, 2026 · NCT06995898

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

RecruitingPhase 1
  • Exelixis Clinical Site #10, Cleveland
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT05176483

National Liver Cancer Screening Trial

RecruitingPhase 4
  • The Cleveland Clinic, Cleveland
Ages 18 to 85 · All sexes · Updated Sep 25, 2026 · NCT06084234

A Study Evaluating a New Radiation Treatment Workflow (NGDS)

Recruiting
  • University Hospital Cleveland Medical Center, Cleveland
Ages 21 and older · All sexes · Updated Sep 17, 2026 · NCT07824583

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

RecruitingObservational study
  • Cleveland Clinic Foundation, Cleveland
Ages 22 and older · All sexes · Updated Sep 11, 2026 · NCT06486454

FOG-001 in Locally Advanced or Metastatic Solid Tumors

RecruitingPhase 1/2
  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
  • Cleveland Clinic, Cleveland
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05919264

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

RecruitingPhase 3
  • Case Western Reserve University, Cleveland
  • UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi away
  • UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22 mi away
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT07166406

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

RecruitingPhase 1
  • University Hospitals Cleveland Medical Center, Cleveland
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT05208762

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

RecruitingPhase 1
  • Clinical Trial Site, Cleveland
Ages 18 and older · All sexes · Updated Jun 17, 2026 · NCT06600321

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Recruiting
  • Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Ages 18 to 75 · All sexes · Updated Jun 17, 2026 · NCT05486572

68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)

RecruitingPhase 2
  • Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT06852820

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

RecruitingPhase 1/2
  • Cleveland Clinic Lerner College of Medicine, Cleveland
Ages 18 and older · All sexes · Updated Apr 27, 2026 · NCT05440708

HOPE Against Cancer Recurrence in HCC

RecruitingPhase 4
  • Cleveland Clinic, Cleveland
Ages 18 and older · All sexes · Updated Dec 16, 2025 · NCT06717919

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi away
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

The Dragon PLC Trial (DRAGON-PLC)

Recruiting
  • Cleveland Clinic, Cleveland
Ages 18 and older · All sexes · Updated May 15, 2025 · NCT06914648

Liver Cancer (Hepatocellular Carcinoma) trials in other cities

Other studies in Cleveland

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.